{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T05:40:13Z","timestamp":1695793213478},"reference-count":16,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T00:00:00Z","timestamp":1205280000000},"content-version":"vor","delay-in-days":6311,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1990,12]]},"abstract":"<jats:p><jats:bold>S<jats:sc>ummary<\/jats:sc><\/jats:bold> The increasing incidence of bacteraemia caused by Gram\u2010positive bacteria in neutropenic patients prompted the authors to evaluate, in a prospective trial, the role of teicoplanin in the treatment of this infection. Over a 15\u2010month period. 76 cases of bacteraemia (out of 265 evaluable episodes of fever) were observed at the Division of Haematology. University La Sapienza. Kome. Of the 76 cases studied, 46 (60%) were caused by Gram\u2010positive bacteria and 28 (37%) were caused by Gram\u2010negative bacilli. All febrile episodes were treated randomly and empirically with piperacillin plus amikacin with or without teicoplanin. Overall, 41 (54%) of the 76 cases of bacteraemia responded to the initial antibiotic regimen: with subsequent modifications the response rate rose to 96%.<\/jats:p><jats:p>In the treatment of Gram\u2010positive bacteraemia. first\u2010line administration of teicoplanin was found to be associated with early defervescence and with a significantly higher rate of success without modification of treatment (P &lt; 0.01). Addition of teicoplanin as second\u2010line therapy produced a favourable outcome in 12 (70%) out of 17 cases of bacteraemia unresponsive to the initial piperacillin + amikacin regimen. No cases of Gram\u2010positive bacteraemia associated with septic shock or adult respiratory distress syndrome were observed in either treatment group. Only two late deaths were observed, and these occurred in patients with streptococcal septicaemia who were not receiving early teicoplanin.<\/jats:p><jats:p>The above data do not endorse the use of glycopeptide antibiotics in the early treatment of fever in neutropenic patients: rather, these compounds should be reserved for proven or presumed Gram\u2010positive infections which do not respond to initial beta\u2010lactam\/aminoglycoside treatment.<\/jats:p>","DOI":"10.1111\/j.1365-2141.1990.tb07930.x","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T11:09:40Z","timestamp":1205320180000},"page":"19-23","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Teicoplanin in the treatment of Gram\u2010positive bacteraemia in neutropenic patients"],"prefix":"10.1111","volume":"76","author":[{"given":"A. Micozzi M.","family":"Venditti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Amadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pulsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Tirindelli","family":"And","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,12]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"25","volume-title":"Current Clinical Topics in Infectious Disease","author":"Archer G.L.","year":"1984"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.7.1126"},{"key":"e_1_2_1_4_1","first-page":"1602","article-title":"Ceftazidime combined with a short or long course of amikacin for empirical therapy of Gram\u2010negative bacteremia in cancer patients with granulocytopenia","volume":"317","author":"European Organization on Research and Therapy of Cancer\u2014international antimicrobial therapy cooperative group","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90440-9"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90257-3"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01743253"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)91169-0"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608283150905"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950040414"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-1-134"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-1-30"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197105132841904"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.4.580"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.2.209"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-4-503"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/archinte.1983.00350010034007","article-title":"Coagulase negative staphylococcal bacteraemia in patients receiving immunosuppressive therapy","volume":"143","author":"Winston D.J.","year":"1983","journal-title":"Archives of Internal Medicine"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.1990.tb07930.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.1990.tb07930.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T14:09:01Z","timestamp":1695737341000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.1990.tb07930.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":16,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["10.1111\/j.1365-2141.1990.tb07930.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.1990.tb07930.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,12]]},"assertion":[{"value":"2008-03-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}